Korea United to patent Atenolol soft capsule.

Published: 2006-03-14 06:57:00

Updated: 2006-03-14 06:57:00

Korea United Pharm. Co. announced on March 9 that a patent for a soft encapsulation of atenolol, a beta-blocker anti-hypertension drug, was completed to register in Korea.

The company explained the patent claims characterized in which atenolol was dissolved in excipients dispensed with one or more of hydrophilic solvents, acidifiers and polyvinylpyrollidon and filled in the soft gelatin cap...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.